Position in ABBV
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$6,318,519
-$250,568 QoQ
Shares Held
29,052
+1.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Reynders McVeigh Capital Management, LLC holds $48,961,420 across 8 Drug Manufacturers - General names. ABBV ranks #3 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
76,014 | $18,580,862 | |
| 2 | NVS |
Novartis AG
|
73,392 | $11,210,628 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
29,052 | $6,318,519 | |
| 4 | LLY |
ELI LILLY & Co
|
5,986 | $5,505,743 | |
| 5 | AMGN |
Amgen Inc
|
9,182 | $3,230,686 | |
| 6 | MRK |
Merck & Co., Inc.
|
22,387 | $2,692,932 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,904 | $1,085,877 | |
| 8 | PFE |
Pfizer Inc
|
11,972 | $336,173 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,318,519 | 29,052 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $6,569,087 | 28,750 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $6,499,327 | 28,070 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $5,483,214 | 29,540 | Shares | Sole | 2025-09-04 | |
| 2025-03-31 | $6,751,362 | 32,223 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $5,987,246 | 33,693 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $6,632,168 | 33,584 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,220,515 | 36,267 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,819,827 | 37,451 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $6,337,808 | 40,897 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $6,205,367 | 41,630 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $5,740,171 | 42,605 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $6,560,784 | 41,167 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $6,610,495 | 40,904 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,860,950 | 43,670 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $6,951,319 | 45,386 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $7,562,755 | 46,652 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $6,531,831 | 48,241 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,207,963 | 48,280 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,403,791 | 47,974 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $5,323,666 | 49,193 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $5,438,505 | 50,756 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,552,490 | 51,975 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $5,178,405 | 52,744 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $3,481,273 | 45,692 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||